ESX system

  • 文章类型: Journal Article
    结核分枝杆菌(Mtb)是在巨噬细胞中存活和生长的细胞内病原体。Mtb用于实现细胞内存活的机制是分泌阻止吞噬体成熟正常过程的效应分子。通过吞噬体成熟停滞(PMA),Mtb保留在早期吞噬体中并避免递送至降解吞噬溶酶体。Mtb的一种PMA效应是分泌的SapM磷酸酶。因为SapM的主机目标,磷脂酰肌醇-3-磷酸酯(PI3P),位于吞噬体的细胞溶质表面,SapM不仅需要由分枝杆菌释放,而且还需要离开吞噬体才能发挥其功能。迄今为止,已知Mtb分子离开吞噬体的唯一机制是ESX-1分泌系统的吞噬体透化。要了解PMA中SapM函数的这一步,我们在两种减毒牛分枝杆菌卡介苗(BCG)疫苗株中产生了相同的框内sapM突变体,缺少ESX-1系统,Mtb。这些突变体的表征表明SapM是BCG和Mtb中PMA所必需的。Further,通过在BCG中建立SAPM在PMA中的作用,随后在缺乏ESX-1系统的Mtb突变体中,我们证明了SapM的作用不需要ESX-1。我们进一步确定ESX-2或ESX-4也不是SapM在PMA中发挥作用所必需的。这些结果表明,SapM是BCG和Mtb中PMA的分泌效应物,并且它可以独立于Mtb分子离开吞噬体的已知机制而起作用。
    Mycobacterium tuberculosis (Mtb) is an intracellular pathogen that survives and grows in macrophages. A mechanism used by Mtb to achieve intracellular survival is to secrete effector molecules that arrest the normal process of phagosome maturation. Through phagosome maturation arrest (PMA), Mtb remains in an early phagosome and avoids delivery to degradative phagolysosomes. One PMA effector of Mtb is the secreted SapM phosphatase. Because the host target of SapM, phosphatidylinositol-3-phosphate (PI3P), is located on the cytosolic face of the phagosome, SapM needs to not only be released by the mycobacteria but also travel out of the phagosome to carry out its function. To date, the only mechanism known for Mtb molecules to leave the phagosome is phagosome permeabilization by the ESX-1 secretion system. To understand this step of SapM function in PMA, we generated identical in-frame sapM mutants in both the attenuated Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine strain, which lacks the ESX-1 system, and Mtb. Characterization of these mutants demonstrated that SapM is required for PMA in BCG and Mtb. Further, by establishing a role for SapM in PMA in BCG, and subsequently in a Mtb mutant lacking the ESX-1 system, we demonstrated that the role of SapM does not require ESX-1. We further determined that ESX-2 or ESX-4 is also not required for SapM to function in PMA. These results indicate that SapM is a secreted effector of PMA in both BCG and Mtb, and that it can function independent of the known mechanism for Mtb molecules to leave the phagosome.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Mycobacterium infection can affect the host\'s immune function by secreting extracellular effector proteins. ESX (or type VII) system plays an important role in the secretion of effector proteins. ESX system is the protein export system in mycobacteria and many actinomycetes. However, how ESX system secretes and underlying mechanism of action remain unclear. In this review, we introduce the components, function, classification of ESX system and the process of substrates transfer to the peripheral space via this system, and discuss the roles of ESX system in antibiotics resistance, persistence, host-phage interaction, new drug targets. We hope to provide insights into the discovery of new drugs and vaccine antigens for tuberculosis.
    分枝杆菌感染宿主后能够通过分泌至胞外的效应蛋白去影响宿主的免疫功能,其中ESX (或VII型)系统在效应蛋白分泌方面发挥了重要作用。ESX分泌系统是分枝杆菌和许多放线菌中的蛋白质输出系统,但目前ESX系统如何将底物运输穿过外膜的分子机制以及调控机制尚不清楚。本文对ESX系统的组成、功能、分类以及将底物运输至周质空间的相关研究进展展开了综述,并探讨了ESX系统在抗生素耐药、持留及与宿主-噬菌体相互作用中的功能,以及作为新药物靶标的潜力,以期为结核病新药物和疫苗抗原的发现提供新的见解。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    疫苗接种是刺激宿主免疫反应并降低人类针对微生物感染的发病率和死亡率的极好方法。如结核病(TB)。卡介苗(BCG)是世界上使用最广泛的疫苗,也是世界卫生组织(WHO)批准的唯一预防结核病的疫苗。尽管BCG赋予儿童“保护性”免疫力,以抵抗结核分枝杆菌(Mtb)感染发展为活动性结核病,这种疫苗在保护患有活动性结核病表现的成年人方面无效,例如多个-,extensive-,和完全耐药(MDR/XDR/TDR)病例以及结核病与免疫受损的健康状况共存,如HIV感染或糖尿病。此外,BCG可在HIV感染或其他免疫受损的个体中引起疾病。由于BCG的这些限制,迫切需要新的策略来改善全球结核病控制措施.由于活疫苗引起更广泛的免疫反应,并且不需要佐剂,开发重组卡介苗(rBCG)候选疫苗作为目前批准的用于结核病预防的卡介苗的潜在替代品受到了极大的关注.在这份报告中,我们的目标是就新型分枝杆菌型结核减毒活疫苗候选物提出我们认为值得研究的最新发现和悬而未决的问题.我们还特别讨论了两个关键动物模型的重要特征,老鼠和兔子,这与结核病疫苗测试有关。我们的综述强调,开发阻止潜伏性Mtb感染(LTBI)重新激活为活动性TB的疫苗将对减少Mtb的传播和传播产生重大影响。这里讨论的结果和想法仅基于过去五年的报告,以保持对最近事态发展的关注。
    Vaccination is an excellent approach to stimulating the host immune response and reducing human morbidity and mortality against microbial infections, such as tuberculosis (TB). Bacillus Calmette-Guerin (BCG) is the most widely administered vaccine in the world and the only vaccine approved by the World Health Organization (WHO) to protect against TB. Although BCG confers \"protective\" immunity in children against the progression of Mycobacterium tuberculosis (Mtb) infection into active TB, this vaccine is ineffective in protecting adults with active TB manifestations, such as multiple-, extensive-, and total-drug-resistant (MDR/XDR/TDR) cases and the co-existence of TB with immune-compromising health conditions, such as HIV infection or diabetes. Moreover, BCG can cause disease in individuals with HIV infection or other immune compromises. Due to these limitations of BCG, novel strategies are urgently needed to improve global TB control measures. Since live vaccines elicit a broader immune response and do not require an adjuvant, developing recombinant BCG (rBCG) vaccine candidates have received significant attention as a potential replacement for the currently approved BCG vaccine for TB prevention. In this report, we aim to present the latest findings and outstanding questions that we consider worth investigating regarding novel mycobacteria-based live attenuated TB vaccine candidates. We also specifically discuss the important features of two key animal models, mice and rabbits, that are relevant to TB vaccine testing. Our review emphasizes that the development of vaccines that block the reactivation of latent Mtb infection (LTBI) into active TB would have a significant impact in reducing the spread and transmission of Mtb. The results and ideas discussed here are only based on reports from the last five years to keep the focus on recent developments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Mycobacterial 6-kDa early secreted antigenic target (ESAT-6) system (ESX) exporters transport proteins across the cytoplasmic membrane. Many proteins transported by ESX systems are then translocated across the mycobacterial cell envelope and secreted from the cell. Although the mechanism underlying protein transport across the mycolate outer membrane remains elusive, the ESX systems are closely connected with and localize to the cell envelope. Links between ESX-associated proteins, cell wall synthesis, and the maintenance of cell envelope integrity have been reported. Genes encoding the ESX systems and those required for biosynthesis of the mycobacterial envelope are coregulated. Here, we review the interplay between ESX systems and the mycobacterial cell envelope.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

  • 文章类型: Journal Article
    The Mycobacterium tuberculosis genome was sequenced more than 15 years ago. It revealed a lot of interesting information, one of which was that 10% of the total coding capacity of the M. tuberculosis genome is dedicated to the PE/PPE family. There is a gradual expansion of these proteins from nonpathogenic to pathogenic mycobacteria, and there is increasing evidence that PE/PPE proteins play important roles in mycobacterial pathogenesis. In this review, we discuss PE/PPE proteins, their close functional association with the ESX clusters, their immunomodulatory functions, and their important roles in mycobacterial virulence. In addition, we have attempted to review and compile information available in the literature detailing the expression patterns of PE/PPE family members in different mycobacterial species and also during infection. Our attempt has been to provide a succinct overview of this interesting family.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号